Cyclo Therapeutics -CW25CYTHWPreferred / convertible
13F holders, Q1 2024 (March 31)2holders
1famous investor
$0.24avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Cyclo Therapeutics -CW25 (CYTHW) in their 13F filings. The largest holders were Citadel Advisors ($3K) and UBS Group AG ($19). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Cyclo Therapeutics -CW25
- CUSIP
- 23254X110
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $19 |
| Exits | 0 | $0 |
Ownership 2 holders
| Citadel Advisors | — | Add +0.2% | 10,993 | $3K |
| UBS Group AG | — | New | 81 | $19 |
"% of holder's portfolio" is CYTHW's weight in each manager's 13F, not the share of Cyclo Therapeutics -CW25 the manager owns.